Staphylococcus aureus nasal carriage in a moroccan dialysis center and isolates characterization

Hemodialysis International

Volumn 17, Issue 4, 2013, Pages 542-547

  Oumokhtar, Bouchra ^a   Elazhari, Mohamed ^b   Timinouni, Mohammed ^b   Bendahhou, Karima ^c   Bennani, Bahia ^a   Mahmoud, Mustapha ^a   El Ouali Lalami, Abelhakim ^d   Berrada, Sanae ^d   Arrayhani, Mohammed ^e   Squalli Houssaini, Tariq ^e  

^a SIDI MOHAMED BEN ABDELLAH UNIVERSITY   (Morocco)

^b Institut Pasteur du Maroc   (Morocco)

^c Department of Epidemiology and Clinical Research   (Morocco)

^d Regional Direction of Health   (Morocco)

^e HASSAN II UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Antimicrobial susceptibility; Hemodialysis; Nasal carriage; Staphylococcus aureus; Virulence factors

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; PANTON VALENTINE LEUKOCIDIN; PEFLOXACIN; PENICILLIN DERIVATIVE; STAPHYLOCOCCUS TOXIN; TETRACYCLINE; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; CLINICAL TRIAL; DISK DIFFUSION; FEMALE; GENETIC VARIABILITY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOROCCO; NONHUMAN; OUTPATIENT; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL SUSCEPTIBILITY; HEMODIALYSIS; NASAL CARRIAGE; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOROCCO; NOSE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84884982801     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00759.x     Document Type: Article

References (38)

1. La lettre de MAGREDIAL. Registre de l'Insuffisance Rénale Chronique Terminale. N°1. 2004. Available from: http://nephro-maroc.org/pages/static/morrocanNephrology/magredial/ (accessed date: January 10, 2012).
2. Wertheim HF, Melles DC, Vos MC, etal. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005; 5:751-762.
3. Arduino MJ, Tokars JI. Why is an infection control program needed in the hemodialysis setting? Nephrol News Issues. 2005; 19:46-49.
4. Von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001; 344:11-16.
5. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005; 33:3-8.
6. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. Prospective study on microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol. 1988; 26:1257-1262.
7. Duran N, Ocak S, Eskiocak AF. Staphylococcus aureus nasal carriage among the diabetic and non-diabetic haemodialysis patients. Int J Clin Pract. 2006; 60:1204-1209.
8. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001; 9:486-493.
9. Committee for Antimicrobial Testing of the French Society of Microbiology. Guidelines 2010. 2010. Available from: http://nosobase.chu-lyon.fr/recommandations/antibiotiques.html (accessed date: October 9, 2012).
10. Chesneau O, Allignet J, el Solh N. Thermonuclease gene as a target nucleotide sequence for specific recognition of Staphylococcus aureus. Mol Cell Probes. 1993; 7:301-310.
11. Vannuffel P, Gigi J, Ezzedine H, etal. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol. 1995; 33:2864-2867.
12. Tristan A, Ying L, Bes M, Etienne J, Vandenesch F, Lina G. Use of multiplex PCR to identify Staphylococcus aureus adhesins involved in human hematogenous infections. J Clin Microbiol. 2003; 41:4465-4467.
13. Jarraud S, Mougel C, Thioulouse J, etal. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002; 70:631-641.
14. Elie-Turenne MC, Fernandes H, Mediavilla JR, etal. Prevalence and characteristics of Staphylococcus aureus colonization among healthcare professionals in an urban teaching hospital. Infect Control Hosp Epidemiol. 2010; 316:574-580.
15. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of methicillin resistant Staphylococcus aureus: The prevalence, patients at risk and the effect of elimination on outcomes among outclinic hemodialysis patients. Eur J Med Res. 2007; 12:284-288.
16. Lozanoa C, Gomez-Sanza E, Benitoa D, Aspirozb C, Zarazagaa M, Torresa C. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. Int J Med Microbiol. 2011; 30:500-505.
17. Bogut A, Kozioł-Montewka M, Baranowicz I, etal. Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing hemodialysis treatment. New Microbiol. 2007; 30:149-154.
18. Souly K, Ait el kadi M, Lahmadi K, etal. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients. Med Mal Infect. 2011; 41:469-474.
19. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997; 10:505-520.
20. Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am J Nephrol. 2007; 27:352-359.
21. Tordoir J, Canaud B, Haage P, etal. EBPG on vascular access. Nephrol Dial Transplant. 2007; 22:88-117.
22. Shittu AO, Okon K, Adesida S, etal. Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BMC Microbiol. 2011; 11:92.
23. Ahmed AO, van Belkum A, Fahal AH, etal. Nasal carriage of Staphylococcus aureus and epidemiology of surgical-site infections in a Sudanese university hospital. J Clin Microbiol. 1998; 36:3614-3618.
24. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staphylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol. 2003; 41:1434-1439.
25. Bania J, Dabrowska A, Korzekwa K, etal. The profiles of enterotoxin genes in Staphylococcus aureus from nasal carriers. Lett Appl Microbiol. 2006; 42:315-320.
26. Jarraud S, Peyrat MA, Lim A, etal. Egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol. 2001; 166:669-677.
27. Nashev D, Toshkova K, Bizeva L, Akineden O, Lämmler C, Zschöck M. Distribution of enterotoxin genes among carriage- and infection-associated isolates of Staphylococcus aureus. Lett Appl Microbiol. 2007; 45:681-685.
28. Durand G, Bes M, Meugnier H, etal. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol. 2006; 44:847-853.
29. Collery MM, Smyth DS, Twohig JM, Shore AC, Coleman DC, Smyth CJ. Molecular typing of nasal carriage isolates of Staphylococcus aureus from an Irish university student population based on toxin gene PCR, agr locus types and multiple locus, variable number tandem repeat analysis. J Med Microbiol. 2008; 57:348-358.
30. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med. 2000; 6:1275-1277.
31. Van Trijp MJ, Melles DC, Snijders SV, etal. Genotypes, superantigen gene profiles and presence of exfoliative toxin genes in clinical methicillin-susceptible Staphylococcus aureus isolates. Diagn Microbiol Infect Dis. 2010; 66:222-224.
32. Peacock SJ, Moore CE, Justice A, etal. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun. 2002; 70:4987-4996.
33. Argudín MA, Mendoza MC, Méndez FJ, etal. Clonal complexes and diversity of exotoxin gene profiles in methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from patients in a Spanish hospital. J Clin Microbiol. 2009; 47:2097-2105.
34. Lina G, Piémont Y, Godail-Gamot F, etal. Involvement of Panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999; 29:1128-1132.
35. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001; 344:11-16.
36. Saxena AK, Saxena AK, Panhotra BR, Chopra R. Advancing age and the risk of nasal carriage of Staphylococcus aureus among patients on long-term hospital-based hemodialysis. Ann Saudi Med. 2004; 24:337-342.
37. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of meticillin resistant Staphylococcus aureus: The prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res. 2007; 12:284-288.
38. Celik G, Gülcan A, Dikici N, Gülcan E. Prevalence of nasal Staphylococcus aureus carriage in the patients undergoing hemodialysis and evaluation of risk factors and laboratory parameters. Ren Fail. 2011; 33:494-498.